131 related articles for article (PubMed ID: 2522537)
1. Targeting and processing of pro-opiomelanocortin in neuronal cell lines.
Noël G; Zollinger L; Laliberté F; Rassart E; Crine P; Boileau G
J Neurochem; 1989 Apr; 52(4):1050-7. PubMed ID: 2522537
[TBL] [Abstract][Full Text] [Related]
2. Investigation of a possible role of the amino-terminal pro-region of proopiomelanocortin in its processing and targeting to secretory granules.
Roy P; Chevrier D; Fournier H; Racine C; Zollinger M; Crine P; Boileau G
Mol Cell Endocrinol; 1991 Dec; 82(2-3):237-50. PubMed ID: 1794612
[TBL] [Abstract][Full Text] [Related]
3. Post-translational processing of pro-opiomelanocortin (POMC)-derived peptides during fetal monkey pituitary development. II. beta-Lipotropin (beta-LPH)-related peptides.
Hatfield JM; Allen RG; Stack J; Ronnekleiv O
Dev Biol; 1988 Mar; 126(1):164-72. PubMed ID: 2963776
[TBL] [Abstract][Full Text] [Related]
4. Peroxisomal localization of the proopiomelanocortin-derived peptides beta-lipotropin and beta-endorphin.
Höftberger R; Kunze M; Voigtländer T; Unterberger U; Regelsberger G; Bauer J; Aboul-Enein F; Garzuly F; Forss-Petter S; Bernheimer H; Berger J; Budka H
Endocrinology; 2010 Oct; 151(10):4801-10. PubMed ID: 20810565
[TBL] [Abstract][Full Text] [Related]
5. 60 YEARS OF POMC: Biosynthesis, trafficking, and secretion of pro-opiomelanocortin-derived peptides.
Cawley NX; Li Z; Loh YP
J Mol Endocrinol; 2016 May; 56(4):T77-97. PubMed ID: 26880796
[TBL] [Abstract][Full Text] [Related]
6. Ontogenesis of proopiomelanocortin and its processing to beta-endorphin by the fetal and neonatal rat brain.
Angelogianni P; Li HL; Gianoulakis C
Neuroendocrinology; 2000 Oct; 72(4):231-41. PubMed ID: 11070427
[TBL] [Abstract][Full Text] [Related]
7. Intracellular proteolytic processing of proopiomelanocortin in heterologous COS-1 cells by the yeast KEX2 endoprotease.
Zollinger L; Racine C; Crine P; Boileau G; Germain D; Thomas DY; Gossard F
Biochem Cell Biol; 1990 Mar; 68(3):635-40. PubMed ID: 2165411
[TBL] [Abstract][Full Text] [Related]
8. Differential release of proopiomelanocortin-derived peptides from the human pituitary: evidence from a panel of two-site immunoradiometric assays.
Gibson S; Crosby SR; Stewart MF; Jennings AM; McCall E; White A
J Clin Endocrinol Metab; 1994 Apr; 78(4):835-41. PubMed ID: 8157708
[TBL] [Abstract][Full Text] [Related]
9. Production of pro-opiomelanocortin (POMC) by a vaccinia virus transient expression system and in vitro processing of the expressed prohormone by POMC-converting enzyme.
Andreasson KI; Tam WW; Feurst TO; Moss B; Loh YP
FEBS Lett; 1989 May; 248(1-2):43-7. PubMed ID: 2542089
[TBL] [Abstract][Full Text] [Related]
10. Targeting of pro-opiomelanocortin to the regulated secretory pathway may involve cooperation between different protein domains.
Chevrier D; Fournier H; Nault C; Zollinger M; Crine P; Boileau G
Mol Cell Endocrinol; 1993 Aug; 94(2):213-21. PubMed ID: 8224524
[TBL] [Abstract][Full Text] [Related]
11. Expression of porcine pro-opiomelanocortin in mouse neuroblastoma (Neuro2A) cells: targeting of the foreign neuropeptide to dense-core vesicles.
Chevrier D; Fournier H; Nault C; Zollinger M; Crine P; Boileau G
Mol Cell Endocrinol; 1991 Aug; 79(1-3):109-18. PubMed ID: 1936537
[TBL] [Abstract][Full Text] [Related]
12. [Pro-opiomelanocortin neuronal systems].
Tranchand-Bunel D; Delbende C; Guy J; Jegou S; Jenks BJ; Mocaër E; Pelletier G; Vaudry H
Rev Neurol (Paris); 1987; 143(6-7):471-89. PubMed ID: 3310184
[TBL] [Abstract][Full Text] [Related]
13. Altered processing of pro-orphanin FQ/nociceptin and pro-opiomelanocortin-derived peptides in the brains of mice expressing defective prohormone convertase 2.
Allen RG; Peng B; Pellegrino MJ; Miller ED; Grandy DK; Lundblad JR; Washburn CL; Pintar JE
J Neurosci; 2001 Aug; 21(16):5864-70. PubMed ID: 11487609
[TBL] [Abstract][Full Text] [Related]
14. Kex2-like endoproteases PC2 and PC3 accurately cleave a model prohormone in mammalian cells: evidence for a common core of neuroendocrine processing enzymes.
Thomas L; Leduc R; Thorne BA; Smeekens SP; Steiner DF; Thomas G
Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5297-301. PubMed ID: 1647029
[TBL] [Abstract][Full Text] [Related]
15. Characterization of peptides derived from pro-opiomelanocortin in the biological fluids of a patient with Nelson's syndrome.
Gaspar L; Chan JS; Seidah NG; Chrétien M
Clin Invest Med; 1985; 8(2):167-75. PubMed ID: 3009068
[TBL] [Abstract][Full Text] [Related]
16. Expression of porcine pro-opiomelanocortin cDNA in an established fibroblastic cell line: constitutive secretion of the precursor without proteolytic processing.
Zollinger L; Noël G; Des Parois L; Sales V; Crine P; Boileau G
Mol Cell Endocrinol; 1988 Jul; 58(1):31-41. PubMed ID: 2463190
[TBL] [Abstract][Full Text] [Related]
17. An in vivo characterization of the cleavage site specificity of the insulin cell prohormone processing enzymes.
Thorne BA; Thomas G
J Biol Chem; 1990 May; 265(15):8436-43. PubMed ID: 2160459
[TBL] [Abstract][Full Text] [Related]
18. Effect of calcium ions on the processing of pro-opiomelanocortin by bovine intermediate lobe pro-opiomelanocortin-converting enzyme.
Birch NP; Bennett HP; Estivariz FE; Loh YP
Eur J Biochem; 1991 Oct; 201(1):85-9. PubMed ID: 1655430
[TBL] [Abstract][Full Text] [Related]
19. Regulation of stress-induced secretion of POMC-derived peptides.
Van Loon GR; De Souza EB
Ann N Y Acad Sci; 1987; 512():300-7. PubMed ID: 2831779
[No Abstract] [Full Text] [Related]
20. 60 YEARS OF POMC: From the prohormone theory to pro-opiomelanocortin and to proprotein convertases (PCSK1 to PCSK9).
Chrétien M; Mbikay M
J Mol Endocrinol; 2016 May; 56(4):T49-62. PubMed ID: 26762158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
